Kopexil

  1. Home
  2. Wiki
Kopexil
Names
IUPAC names
2,3-Dihydro-3-hydroxy-2-imino-4-pyrimidinamine
2,4-Diaminopyrimidine 3-N-oxide
Other names
Aminexil
Identifiers
3D model (JSmol)
ChemSpider
EC Number
  • 616-121-2
UNII
  • InChI=1S/C4H6N4O/c5-3-1-2-7-4(6)8(3)9/h1-2H,5H2,(H2,6,7)
    Key: SGHQFNHCCOBUKB-UHFFFAOYSA-N
  • InChI=1S/C4H6N4O/c5-3-1-2-7-4(6)8(3)9/h1-2,6,9H,5H2
    Key: YTKGAYFHUZTLCI-UHFFFAOYSA-N
  • c1cnc([n+](c1N)[O-])N
Properties
C4H6N4O
Molar mass 126.119 g·mol−1
Appearance white odorless crystals[1]
Melting point 210 to 218 °C (410 to 424 °F; 483 to 491 K)[1]
slightly soluble[1]
Hazards
GHS labelling:
GHS07: Exclamation mark
Warning
H302
P264, P270, P301+P312, P330, P501
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

Kopexil (INCI name diaminopyrimidine oxide, trade name Aminexil) is a chemical compound similar to minoxidil. Minoxidil was originally used to treat high blood pressure; a side effect was increased body hair. Both compounds have been used for therapy of alopecia.[2] Kopexil is not approved for use as a drug in the United States or in Europe.

Chemical structure

[edit]

Kopexil is an N-oxide, a group of substances in which the nitrogen atom of a tertiary amine is oxidized. The compound can exist in two tautomeric forms.

Mechanism of action

[edit]

The exact mechanism of action of kopexil is unknown. There is no proof of therapeutic effect for kopexil against alopecia.[3]

References

[edit]
  1. ^ a b c MSDS for Kopexil at Kumar Organics. Archived 2015-07-22 at the Wayback Machine March 28th 2012.
  2. ^ Trüeb, RM; de Viragh, PA (February 2001). "[Status of scalp hair and therapy of alopecia in men in Switzerland]". Praxis (Bern 1994). 90: 241–8. PMID 11256223.
  3. ^ Wolfgang Raab: Haarerkrankungen in der dermatologischen Praxis, p. 82, at Google Books (German).
Stub icon

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This dermatologic drug article is a stub. You can help Wikipedia by expanding it.